You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
樂普醫療(300003.SZ):心泰科技擬增資擴股融資 包括紅杉資本、鼎暉投資等旗下基金
格隆匯 05-31 19:16

格隆匯5月31日丨樂普醫療(300003.SZ)公佈,公司控股子公司樂普心泰醫療科技(上海)股份有限公司(以下簡稱心泰科技)為滿足經營發展的需要,通過增資擴股進行融資,公司擬放棄此次對心泰科技增資的優先認繳出資權。

經交易各方充分溝通,以此次投資前心泰科技整體估值9.5億美元為基礎,此次融資金額不超過9517.7261萬美元其中計入註冊資本不超過2955.8155萬元人民幣。

交易對方分別為維梧資本旗下基金Vivo Capital Fund IX, L.P.,紅杉資本旗下基金SCC Growth VI Holdco AF, Ltd.,上海生物醫藥產業股權投資基金合夥企業(有限合夥),鼎暉投資旗下基金CDH Supermatrix D Limited,懷化皓智企業管理合夥企業(有限合夥)。

次增資擴股前,心泰科技股權結構如下:

次增資擴股完成後,心泰科技股權結構如下:

心泰科技主要從事結構性心臟病介入用醫療器械的研發、生產和商業化核心產品主動脈瓣膜置換產品和二尖瓣修復夾子系統都處在研發階段,需要投入巨大的研發費用,支撐上述產品的國內和國際研發及臨牀研究。本次增資能夠促心泰科技上述產品的產業化進程,同時有效降低公司的投資風險。此次增資完成後公司持有心泰科技股權比例不低於86.3412%,心泰科技仍為公司股子公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account